Trade Mark Journal No.2025/051 19 December 2025

UK00004308913 11 December 2025 (5,42,44)

KYLOKTI

Class 5
Anti-cancer preparations; pharmaceutical products for the treatment of cancer; biological preparations for the treatment of cancer; gene therapy pharmaceutical and biological preparations for the treatment of cancer.
Class 42
Providing information on the subject of scientific research in the field of biochemistry and biotechnology; providing medical research and scientific research information in the field of oncology via the Internet; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics.
Class 44
Medical information; Providing medical information via a website; Providing medical information in the field of the diagnosis and treatment of cancer.

enGene Inc.

Representative: Squire Patton Boggs (UK) LLP